Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Alexandre Castro-Caldas »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Alexandre Castro Caldas < Alexandre Castro-Caldas < Alexandre Eusebio  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000353 (2006) Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France]The Parkinson–Control study: A 1‐year randomized, double‐blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
000384 (2006) Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France]The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's disease
000455 (2003) Marc Ziegler ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France]Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6‐month, randomized, placebo‐controlled study

List of associated KwdEn.i

Nombre de
documents		Descripteur
2Adult
2Aged
2Double blind study
2Double-Blind Method
2Drug Therapy, Combination
2Female
2Follow-Up Studies
2Humans
2Levodopa
2Male
2Middle Aged
2Parkinson Disease (drug therapy)
2Parkinson disease
2Parkinson's disease
2Piribedil
2Treatment Outcome
2piribedil
1Agonist
1Antiparkinson Agents (administration & dosage)
1Antiparkinson Agents (adverse effects)
1Antiparkinson Agents (therapeutic use)
1Antiparkinson agent
1Bromocriptine
1Bromocriptine (therapeutic use)
1Case-Control Studies
1Chemotherapy
1Dopamine agonist
1Dopamine receptor
1Dose-Response Relationship, Drug
1Drug Administration Schedule
1Drug combination
1Human
1Levodopa (administration & dosage)
1Levodopa (adverse effects)
1L‐dopa
1Nervous system diseases
1Parkinson Disease (diagnosis)
1Piribedil (administration & dosage)
1Piribedil (adverse effects)
1Piribedil (therapeutic use)
1Severity of Illness Index
1Time Factors
1Treatment
1Treatment efficiency
1bromocriptine
1dopamine agonists
1levodopa
1nonfluctuating patients

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Alexandre Castro-Caldas" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Alexandre Castro-Caldas" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Alexandre Castro-Caldas
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024